Mandy L Ballinger

19PUBLICATIONS
145CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Haematological tumoursLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 16, 2026
Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.

|Apr 24, 2026
Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT Trial.

|Apr 23, 2026
Impact of Spiritual Wellbeing in Advanced Cancer Patients Receiving Genomic Test Results.

|Mar 27, 2026
Challenging interpretation of low-level PTCH1 mosaicism in patients with clinically diagnosed Gorlin syndrome: a case series and review of the literature.

Tanya M Dwarte, Rozanna Alli, Shweta Srinivasa

|Jan 02, 2026
A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.

Gregory M Cote, Mason Aberoumand, Edwin Choy

|May 07, 2024
From ownership to custodianship of tumor biopsy tissue in genomic testing: a mixed methods study of patient views.

Megan C Best, Phyllis Butow, Jacqueline Savard

Pageof 4

Frequent Collaborators

16 joint publications

David Thomas

10 joint publications

Megan C Best

10 joint publications

Phyllis Butow

9 joint publications

Christine Napier